Bidda Rolin

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways

Günaj Rakipovski, Bidda Rolin, Jane Nøhr et al. · JACC Basic to Translational Science · 2018 · 488 citations · Full text

Veterinary Medicine, Cardiology, Pharmacology +17

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.

Jannie Fuhlendorff, Patrik Rorsman, Hans Kofod et al. · Diabetes · 1998 · 313 citations

Medicine, Endocrinology, Pharmacology +16

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice

Bidda Rolin, Marianne O. Larsen, C. F. Gotfredsen et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 280 citations

Medicine, Endocrinology, Pharmacology +17

Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not

Kirsten Raun, Pia von Voss, C. F. Gotfredsen et al. · Diabetes · 2006 · 211 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +17

GLP‐1 derivative liraglutide in rats with <i>β</i>‐cell deficiencies: influence of metabolic state on <i>β</i>‐cell mass dynamics

Jeppe Sturis, C. F. Gotfredsen, John Rømer et al. · British Journal of Pharmacology · 2003 · 200 citations · Full text

Medicine, Endocrinology, Pharmacology +17